good value @ current level, page-3

Thanks, yogi

QRX dropped to as low as 50c when receiving first CSL in 2012,
then bounced back to 92c,
drifted to 65-70c for few months,
steadily climbed to $1 on resubmitted NDA application on 28/02/2013
fetched $1.37 on 11/03/2013 within 2 weeks after re-submission of NDA

This time,
I reckon we are currently forming the bottom (65-70c),
just start climbing back to $1.

General meeting will be held on 13/11/2013.
NDA is scheduled to be resubmitted mid-November.

QRX should move back $1.

POH share price soared by 50% on positive news of Phase 1 Trial.

QRX is in final stage of releasing the drug.